Skip to main content
Home
  • Global
  • Careers
  • Investors
  • About us
    Fagron company profile

    Activities of Fagron

    Leadership team

    Introduction to members of the Leadership team

    Key figures

    Fagron's key figures in one overview

  • Press
    • Press releases
    • Press kit
  • Publications
    Annual reports

    Please find here our annual reports

    Presentations

    Presentations and conference calls

    Statutory annual accounts

    Please find here the statutory annual accounts

    Prospectus September 2007

    Prospectus of the Initial Public Offering

    Prospectus June 2012

    Prospectus of the 4.75% bond

    Prospectus June 2016

    Prospectus of the capital increase

    Bond

    Compliance certificates and guarantor lists

  • Share
    Share performance

    Look at the actual share performance

    Notification of shareholdings

    Shareholding declaration obligation 

    Dividend

    Dividend policy of Fagron

    Shareholders' meetings

    Documents relating to shareholders' meetings

    Analyst coverage

    Analysts covering Fagron

    Shareholder structure

    Overview of participations

  • Events
    Calendar

    Upcoming events

  • Corporate Governance
    Board of Directors

    Members of the Fagron's Board of Directors

    Leadership team

    Introduction to members of the Leadership team

    Governance documents

    Corporate governance documents

Search form

Go to share performance
  • Shareholders
Print Friendly and PDF
Share by mail

Press releases archive

  • Disclosure of received notifications 06 December 2019 Continue reading
  • Disclosure of received notifications 26 November 2019 Continue reading
  • Final settlement with US Department of Justice 07 November 2019 Continue reading
  • Disclosure of received notifications 07 November 2019 Continue reading
  • Disclosure of received notification 01 November 2019 Continue reading
  • Fagron settles with former owner of AnazaoHealth 31 October 2019 Continue reading
  • Fagron increases share capital through warrant exercises 30 October 2019 Continue reading
  • Disclosure of received notification 28 October 2019 Continue reading
  • Changes to the Board of Directors of Fagron 25 October 2019 Continue reading
  • Disclosure of received notification 24 October 2019 Continue reading

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »

About Fagron

Fagron is the leading global pharmaceutical compounding company, bringing customized pharmaceutical care to hospitals, pharmacies, clinics and patients in 35 countries worldwide.

Press releases

Sign up to receive our latest press releases.

Subscribe

Contact us

  • +31 (0) 88 33 11 200
  • investors@fagron.com

Contact information

© Copyright 2019 Fagron.

  • Disclaimer
  • Privacy Statement